Best Semaglutide Providers in 2026 — Ranked & Reviewed

Looking for a trusted semaglutide provider? We independently scored every major telehealth clinic offering compounded and brand-name semaglutide in 2026. Each provider is evaluated on pricing transparency, clinical oversight, shipping, and user experience — so you can find a legitimate, affordable option without falling for sketchy ads.

Lowest verified price: $49/mo498 providers compared

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

498 semaglutide providers compared · independently scored against our six-factor methodology.

Quick Picks: Top 5

#ProviderScore
1CoreAge RxVisit
2FoundVisit
3CollectiveVisit
4Enhance MDVisit
5GalaVisit

Compare the top providers at a glance

Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.

  • ★ Editor's Pick
    CoreAge Rx

    best overall value

    From /mo
    $99
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Nationwide Coverage
    Found

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Best Budget
    Collective

    the lowest flat medication price if you can absorb an annual membership fee

    From /mo
    $59
    Flat at every dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
  • Enhance MD

    lab-monitored compounded GLP-1 with mandatory video visit

    From /mo
    $112
    Flat at every dose
    Coverage
    39 states
    Medications
    SemaglutideTirzepatide
  • Gala

    compounded GLP-1/GIP combo on a yearly plan with free shipping

    From /mo
    $1299
    Flat at every dose
    Coverage
    50 states
    Medications
    TirzepatideSemaglutide
  • bmiMD

    mainstream telehealth GLP-1 access

    From /mo
    $99
    Flat at every dose
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • Transparent Pricing
    RxSpan MD

    physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

    From /mo
    $249
    Coverage
    50 states
    Medications
    SemaglutideTirzepatide
  • GobyMeds

    budget-conscious shoppers

    From /mo
    $93
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatide
6scored dimensions
498semaglutide providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

Detailed Reviews

1

CoreAge Rx

Verified partner

Best for: best overall value

8.3

CoreAge Rx offers LegitScript-certified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8.5
Trust & Safety15%
7.8
Accessibility10%
8
Support10%
8.4

Pros

  • ✓LegitScript certified — rigorous pharmacy standards
  • ✓Free 2-day shipping nationwide
  • ✓Both semaglutide and tirzepatide available
  • ✓Lowest per-month pricing in the compounded segment
  • ✓24/7 support team
  • ✓All 50 states covered

Cons

  • ✗Compounded only — no brand-name Ozempic or Wegovy
  • ✗Newer brand with fewer independent reviews than legacy players
2

Found

Verified partner

Best for: mainstream telehealth GLP-1 access

8.3

Personalized weight care platform with a self-pay membership model plus medication costs.

Score Breakdown

Value25%
8.5
Effectiveness25%
9
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8.5
Support10%
7.5

Pros

  • ✓Aggressively low monthly pricing
  • ✓Both semaglutide and tirzepatide available
  • ✓Compounded GLP-1 access

Cons

  • ✗Limited public information on program details
3

Collective

Verified partner

Best for: the lowest flat medication price if you can absorb an annual membership fee

8.3

Collective (collective.org) is a membership-based telehealth platform from the founder of Thrive Market, selling compounded semaglutide and tirzepatide at a flat price on every dose. Medication is billed separately from a required annual membership, and the program bundles unlimited clinician messaging, dietitian access and express cold shipping.

Score Breakdown

Value25%
9.4
Effectiveness25%
8.2
User Experience15%
8
Trust & Safety15%
7.2
Accessibility10%
7.4
Support10%
8.4

Pros

  • ✓The lowest published compounded GLP-1 medication prices we track — $59/month semaglutide and $69/month tirzepatide
  • ✓Flat pricing at every dose, so titrating up does not raise the bill
  • ✓Unlimited clinician messaging and registered-dietitian access are included rather than upsold
  • ✓21-day free trial on the membership before the annual fee is charged

Cons

  • ✗The advertised $59 and $69 exclude a mandatory $199 annual membership — the real first-year cost is $907 and $1,027
  • ✗Membership fees are non-refundable and no partial-period refunds are given
  • ✗Compounding pharmacies are described only as 'independent, third-party licensed pharmacies' and are never named
  • ✗State availability is not published on the marketing site
4

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.2

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).

Score Breakdown

Value25%
7
Effectiveness25%
9
User Experience15%
8.5
Trust & Safety15%
8
Accessibility10%
8.5
Support10%
8.9

Pros

  • ✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
  • ✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
  • ✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
  • ✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
  • ✓Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
  • ✓Unlimited clinician messaging and dose-adjustment support included

Cons

  • ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • ✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
  • ✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
  • ✗No insurance accepted — cash pay, HSA/FSA eligible
  • ✗Intro discount applies only to the first order — ongoing rates are $212–$322/mo on 12-month plans, or $249–$379/mo month-to-month
5

Gala

Verified partner

Best for: compounded GLP-1/GIP combo on a yearly plan with free shipping

8.2

Gala (legal entity AI Coaching Inc., d/b/a Gala GLP-1) is a Delaware-incorporated telehealth platform selling compounded GLP-1/GIP (tirzepatide) on a yearly subscription, a lower-priced microdosing version of the same protocol, and brand-name Ozempic. It does not sell a compounded semaglutide product. The marketing site claims licensed providers in all 50 states with free shipping included. An oral Wegovy pill option is listed as 'coming soon.'

Score Breakdown

Value25%
8.5
Effectiveness25%
8.5
User Experience15%
8
Trust & Safety15%
7.3
Accessibility10%
8
Support10%
8.4

Pros

  • ✓Compounded semaglutide and tirzepatide at $179/mo with all doses included on the yearly plan
  • ✓Lower microdosing tirzepatide tier at $149/mo for a sub-therapeutic starting protocol
  • ✓Brand-name Ozempic available alongside compounded options
  • ✓Claims licensed providers in all 50 states with free shipping included
  • ✓24/7 support, provider visit included, cancel anytime
  • ✓LegitScript certified

Cons

  • ✗$179/mo requires a yearly subscription — the standalone monthly price isn't published
  • ✗Brand-name Ozempic at $1,299/mo is higher than peers (e.g., Found at $1,100/mo)
  • ✗Pharmacy partners not named — only a "network of pharmacies" reference
  • ✗Wegovy oral pill listed as "coming soon," not yet available
  • ✗Per-state availability isn't listed; the all-50-states claim is gated behind intake

How to choose a semaglutide provider

Semaglutide (Wegovy, Ozempic, and compounded versions) is the most-prescribed GLP-1. The molecule is the same everywhere — what differs is the pharmacy, the clinical care, and the true monthly cost.

What to look for

  • Brand vs. compounded. Decide whether you want FDA-approved brand-name Wegovy/Ozempic (higher cost, standardized dosing) or lower-cost compounded semaglutide from a licensed pharmacy. Providers that offer both give you room to switch.
  • Dose-titration support. Semaglutide is titrated over months. Favor providers whose clinicians adjust the schedule and slow it down if side effects hit, rather than a fixed ladder with no flexibility.
  • All-in monthly price. Compare the ongoing price after any intro month, plus any membership fee — not just the headline number.

Red flags to avoid

  • No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
  • Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
  • Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
  • Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.

Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.

How we rank & what counts as “legit”

Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support. Compounded GLP-1s from licensed 503A and 503B pharmacies are legal under federal compounding law[2], with additional tolerances historically allowed while semaglutide and tirzepatide were on the FDA Drug Shortage List[3].

Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].

Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].

Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Frequently Asked Questions

Yes. Semaglutide — brand-name (Wegovy, Ozempic) and compounded — is prescription-only in the US. The providers ranked above include an online medical consultation; a clinician reviews your intake and decides whether it's appropriate. Any site selling semaglutide with no prescription is not operating legally and is a safety risk.
They're the same molecule (semaglutide). Wegovy is FDA-approved for weight loss and titrates to a higher 2.4 mg dose; Ozempic is approved for type 2 diabetes and tops out at 2 mg, though it's often prescribed off-label for weight. For weight loss specifically, Wegovy is the on-label choice — but compounded semaglutide gives the same active ingredient at a lower cash price.
Two routes lower the cost: the manufacturer savings card (for eligible insured patients) can cut brand-name Wegovy/Ozempic, and compounded semaglutide through telehealth providers often runs $79–$199/month cash versus $1,000+ for the brand. The ranked list above sorts real monthly totals so you can find the lowest legitimate price.
Each provider is evaluated across six weighted dimensions: Value (25%), Effectiveness (25%), User Experience (15%), Trust & Safety (15%), Accessibility (10%), and Support (10%). We research publicly available information, user reviews, clinical evidence, and pricing data, then compute a weighted overall score out of 10.
Each provider's score is computed independently using the six-dimension methodology, and a commercial relationship never changes a provider's underlying score — you can see every provider's full score on its card. Some providers have affiliate agreements with us, meaning we earn a commission if you click through and make a purchase. On our highest-commercial-intent lists — including the semaglutide, tirzepatide, compounded and cheapest molecule lists, the weight-loss injection and shot lists, and the fitness-app list — we feature affiliate partners in the top positions; on every other list the order follows the score (or, for the cheapest lists, the lowest price) directly. This placement is disclosed here and on our methodology and affiliate-disclosure pages.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.